Roivant Sciences (ROIV) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ROIV Roivant Sciences

Watchlist

11.020
-0.500-4.34%

Close Jan 8 16:00 ET

11.150
+0.130+1.18%

Post 20:01 ET

8.02BMarket Cap1.89P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Seeking AlphaJan 7 14:58 ET
Express News | Roivant Sciences Ltd : Guggenheim Cuts Target Price to $15 From $16
ReutersJan 3 06:28 ET
Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing
Yahoo FinanceJan 2 03:21 ET
Roivant Sciences(ROIV.US) Officer Sells US$4.14 Million in Common Stock
Moomoo NewsDec 31 21:07 ET
Express News | Form 144 | Roivant Sciences(ROIV.US) Officer Proposes to Sell 4.23 Million in Common Stocks
Moomoo NewsDec 27, 2024 16:59 ET
Insider Sale: Pres&Chief Investment Officer of $ROIV (ROIV) Sells 10,796 Shares
Quiver QuantitativeDec 26, 2024 21:15 ET

Comments

104129527

Dec 12, 2024 08:55

$Roivant Sciences (ROIV.US)$ Founder vivek ramaswamy going take action with Elon musk.

Meltyy

Dec 5, 2024 06:32

🚀 12 upcoming PDUFAs in December ❄️

Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...

Jaguar8

Dec 3, 2024 06:07

NEWS

$Roivant Sciences (ROIV.US)$
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
6 minutes ago, 4:00 AM PST
Via GlobeNewswire
ROIVROIVW
Share
• Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis
• Further development of namilumab for the treatment of sarcoidosis will be discontinued

Meltyy

May 16, 2024 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Movers and Shakers

Apr 2, 2024 07:16

Columns Today's Morning Movers and Top Ratings: DIS, DASH, CVS, GE and More

Morning Movers
Gapping up
$DoorDash (DASH.US)$ stock rose 0.4% after CFRA Research upgraded its investment stance on the food delivery platform to buy from hold, citing its high growth potential.
$Roivant Sciences (ROIV.US)$ stock rose 7.2% after the biotech said its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study.
Gapping down
$NIO Inc (NIO.US)$ fell ...

Heat List

Overall

No Data